In line with this, it was demonstrated that the disruption of PD-L1/CD80 cis binding by CD80 antibodies can alleviate autoimmunity due to the accessibility of the PD-1/PD-L1 interaction [103]. The gene discussed is CD80; the disease is Autoimmunity.